re: Ann: Prana's PBT2 named one of Top Ne... Even though Prana's PBT2 has a chance of proving some success the latest research suggests that abnormalities in systemic copper metabolism are one of the pathogenetic pathways involved in the AD cascade.
Copper phenotype in Alzheimer’s disease: dissecting the pathway
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703119/
Ann: Prana's PBT2 named one of Top Neuroscien, page-15
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
-0.001(25.0%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $8.591K | 2.273M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 24 | 26968359 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 129390846 | 29 |
View Market Depth
| Last trade - 16.10pm 30/09/2024 (20 minute delay) ? |
| ATH (ASX) Chart |